IVIM Technology (XKRX:460470) Debt-to-Asset : 0.07 (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is IVIM Technology Debt-to-Asset?

IVIM Technology's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₩535 Mil. IVIM Technology's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₩1,812 Mil. IVIM Technology's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was ₩34,897 Mil. IVIM Technology's debt to asset for the quarter that ended in Sep. 2024 was 0.07.

IVIM Technology Debt-to-Asset Historical Data

The historical data trend for IVIM Technology's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IVIM Technology Debt-to-Asset Chart

IVIM Technology Annual Data

Trend

Dec21

Dec22

Dec23

Debt-to-Asset

0.34

0.13

0.15

IVIM Technology Quarterly Data
	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Asset	Get a 7-Day Free Trial			-	0.15	0.16	0.17	0.07

Competitive Comparison of IVIM Technology's Debt-to-Asset

For the Medical Devices subindustry, IVIM Technology's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IVIM Technology's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IVIM Technology's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where IVIM Technology's Debt-to-Asset falls into.

IVIM Technology Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

IVIM Technology's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(295.143	+	2132.199)	/	16531.124
	=	0.15

IVIM Technology's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(535.126	+	1812.116)	/	34897.258
	=	0.07

IVIM Technology (XKRX:460470) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

IVIM Technology Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of IVIM Technology's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

IVIM Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IVIM Technology Inc (XKRX:460470) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Yuseong-gu Techno 4-ro 17, Daedeok Biz Center B-dong 408, 413, 414, 415, Gwanpyeong-dong, Daejeon Metropolitan City, KOR

Website

https://www.ivimtech.com

IVIM Technology Inc is engaged in the manufacturing of cameras, other optical instruments, and photographic equipment. The company technology enables the analyze vivo efficacy of new biopharmaceuticals such as immunological, cell, gene, and antibody therapeutic agents acting in real living organisms at the cellular level.

IVIM Technology Headlines

No Headlines